EUVIMEDEUVIMED entdecken
Vergleichsstudie

Extending a liver-based model to lung and intestine: a comparative study of CYP1A1 and CYP1A2 induction by cigarette smoke in human in vitro models

Ann-Kathrin Lenich iD, Wataru Kishimoto iD, Hiroshi Nakase iD, Tatsuya Inui, Hiroyuki Mizuguchi iD, Stephanie Ruez iD

Archives of Toxicology · 2026

DOI: 10.1007/s00204-026-04313-2 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Archives of Toxicology, 2026. Verfasst von Ann-Kathrin Lenich und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Ri…. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP1A1, Cytochrome P-450 CYP1A2, Lung, Smoke. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cigarette smoke contains over 5000 compounds, including polycyclic aromatic hydrocarbons, which induce cytochrome P450 (CYP) enzymes, particularly CYP1A1 and CYP1A2. Therefore, smoking significantly alters drug metabolism and can reduce therapeutic efficacy. To investigate tissue-specific CYP enzyme induction by cigarette smoke extract (CSE), a previously established hepatic in vitro smoke induction model was expanded to include human intestinal organoids and lung cell models. CYP1A1, CYP1A2, and CYP3A4 mRNA expression and CYP1A1 and CYP1A enzyme activity were quantified following CSE exposure. CYP1A1 mRNA expression and enzyme activity were robustly induced in all tissues and donors (up to 77-fold and 212-fold respectively). CYP1A2 mRNA and CYP1A enzyme activity were induced in liver and intestine (up to 13-fold) but were only weakly detectable in lung. CYP3A4 induction was exclusively observed in liver (up to 16-fold). Comparison of F2- and Emax-values of concentration-dependent induction across all models revealed that intestinal cells showed significantly lower values of CYP1A1 induction than liver cells. Other comparisons were non-significant. Inter-donor variability was visible across all cell models, CYP enzymes and tissue types (57-82% CV). This reflects physiological inter-individual variability, supporting the conclusion that these single-cell models capture donor-specific differences. Conclusively, it was shown that extrahepatic metabolism is altered by CSE and that considering tissue-specific CYP enzyme induction may be beneficial in clinical pharmacology to optimize drug efficacy and safety in smoking populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP1A1Cytochrome P-450 CYP1A2LungSmokeLiverIntestinesHumansEnzyme InductionRNA, MessengerCytochrome P-450 CYP3AOrganoidsMaleIntestinal MucosaSmoking

Stichwörter der Autor:innen

CYP enzymesCigarette smokingEnzyme inductionIntestinal organoidsLung epithelial cellsPrimary human hepatocytes

Substanzen

Cytochrome P-450 CYP1A1Cytochrome P-450 CYP1A2SmokeCYP1A2 protein, humanCYP1A1 protein, humanRNA, MessengerCytochrome P-450 CYP3ACYP3A4 protein, human

Autor:innen und Institutionen

  • Department of Global Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany.
  • Department of Global Drug Metabolism and Pharmacokinetics, Nippon Boehringer Ingelheim Co., Ltd, 6-7-5 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University School of Medicine, S-1, W-16, Chuo-ku, Sapporo, 060-8543, Japan.
  • Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Laboratory of Hepatocyte Regulation, National Institutes of Biomedical Innovation, Health and Nutrition, 7-6-8, Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • The Center for Advanced Medical Engineering and Informatics, The University of Osaka, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.

ORCID-Profile: Ann-Kathrin Lenich, Wataru Kishimoto, Hiroshi Nakase, Hiroyuki Mizuguchi, Stephanie Ruez

Zitieren

APA

Lenich, A. K., Kishimoto, W., Nakase, H., Inui, T., Mizuguchi, H., & Ruez, S. (2026). Extending a liver-based model to lung and intestine: a comparative study of CYP1A1 and CYP1A2 induction by cigarette smoke in human in vitro models. Archives of Toxicology. https://doi.org/10.1007/s00204-026-04313-2

Vancouver

Lenich AK, Kishimoto W, Nakase H, Inui T, Mizuguchi H, Ruez S. Extending a liver-based model to lung and intestine: a comparative study of CYP1A1 and CYP1A2 induction by cigarette smoke in human in vitro models. Archives of Toxicology. 2026. doi:10.1007/s00204-026-04313-2

BibTeX
@article{Lenich2026,
  author = {Lenich, Ann-Kathrin and Kishimoto, Wataru and Nakase, Hiroshi and Inui, Tatsuya and Mizuguchi, Hiroyuki and Ruez, Stephanie},
  title = {Extending a liver-based model to lung and intestine: a comparative study of CYP1A1 and CYP1A2 induction by cigarette smoke in human in vitro models},
  journal = {Archives of Toxicology},
  year = {2026},
  doi = {10.1007/s00204-026-04313-2}
}
Kostenlos starten →